Preventable adverse drug events: Descriptive epidemiology.

Abstract

AimOur objective was to identify preventable adverse drug events and factors contributing to their development.MethodsWe performed a retrospective chart review combining data from three prospective multicentre observational studies that assessed emergency department patients for adverse drug events. A clinical pharmacist and physician independently reviewed the charts, extracted data and rated the preventability of each adverse drug event. A third reviewer adjudicated all discordant or uncertain cases. We calculated the proportion of adverse drug events that were deemed preventable, performed multivariable logistic regression to explore the characteristics of patients with preventable events, and identified contributing factors.ResultsWe reviewed the records of 1 356 adverse drug events in 1 234 patients. Raters considered 869 (64.1%) of adverse drug events probably or definitely preventable. Patients with mental health diagnoses (OR 1.8; 95% CI 1.3–2.5) and diabetes (OR 1.7; 95% CI 1.2–2.4) were more likely to present with preventable events. The medications most commonly implicated in preventable events were warfarin (9.4%), hydrochlorothiazide (4.5%), furosemide (4.0%), insulin (3.9%) and acetylsalicylic acid (2.7%). Common contributing factors included inadequate patient instructions, monitoring and follow‐up, and reassessments after medication changes had been made.ConclusionsOur study suggests that patients with mental health conditions and diabetes require close monitoring. Efforts to address the identified contributing factors are needed.